Iyer Prema C, Yagi Haruhiko, Sayer Jane M, Jerina Donald M
Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, DHHS, Bethesda, Maryland 20892, USA.
Chem Res Toxicol. 2007 Feb;20(2):311-5. doi: 10.1021/tx600282y.
A synthetic route to oligonucleotides containing N(2)-deoxyguanosine adducts at C-10 of the enantiomeric 7,8-diol 9,10-epoxides of 7,8,9,10-tetrahydrobenzo[a]pyrene in which the epoxide oxygen and the 7-hydroxyl group are trans is described. The present adducts result from the trans addition of N(2) of deoxyguanosine to the epoxide at C-10. Our synthesis proceeds via preparation of the 3'-H-phosphonate of a suitably protected deoxyguanosine N(2)-adduct. The blocking groups consisted of O(6)-allyl on the deoxyguanosine, acetates on the 7-, 8-, and 9-hydroxyl groups of the hydrocarbon moiety, and dimethoxytrityl on the 5'-hydroxyl group of the sugar. These blocking groups are well suited to oligonucleotide synthesis on solid supports. The free 3'-hydroxyl group of this nucleoside adduct was readily converted to its 3'-H-phosphonate with diphenyl phosphite in pyridine in high yield for both the 10R and 10S isomers. For synthesis of oligonucleotides, the first several nucleotides were incorporated onto the solid support with an automated synthesizer using standard phosphoramidite chemistry. The adducted deoxyguanilic acid residue was introduced as the H-phosphonate in a manual step (80% yield), followed by completion of the sequence on the synthesizer. Although a 10-fold excess of the 3'-H-phosphonate was used in the manual coupling step, as much as 70% of the reactant could be recovered. The 3'-H-phosphonate of the protected 10S nucleoside adduct was converted to the unblocked nucleotide adduct, various salts of which failed to form crystals suitable for X-ray analysis. Although submilligram quantities of this compound have been formed as mixed diastereomers by direct reaction of deoxyguanylic acid with racemic diol epoxide, the present study represents the first actual synthesis of the major DNA adduct formed from benzo[a]pyrene in mammals as its 3'-phosphate.
描述了一种合成路线,用于制备在7,8,9,10-四氢苯并[a]芘对映体7,8-二醇9,10-环氧化物的C-10位含有N(2)-脱氧鸟苷加合物的寡核苷酸,其中环氧化物氧和7-羟基为反式。本加合物是由脱氧鸟苷的N(2)反式加成到C-10位的环氧化物上形成的。我们的合成通过制备适当保护的脱氧鸟苷N(2)-加合物的3'-H-膦酸酯进行。保护基团包括脱氧鸟苷上的O(6)-烯丙基、烃部分7-、8-和9-羟基上的乙酸酯以及糖5'-羟基上的二甲氧基三苯甲基。这些保护基团非常适合在固体支持物上进行寡核苷酸合成。该核苷加合物的游离3'-羟基很容易用亚磷酸二苯酯在吡啶中高产率地转化为其3'-H-膦酸酯,10R和10S异构体均如此。对于寡核苷酸的合成,前几个核苷酸使用标准亚磷酰胺化学方法通过自动合成仪连接到固体支持物上。在一个手动步骤中以H-膦酸酯的形式引入加合的脱氧鸟苷酸残基(产率80%),然后在合成仪上完成序列。尽管在手动偶联步骤中使用了10倍过量的3'-H-膦酸酯,但多达70%的反应物可以回收。受保护的10S核苷加合物的3'-H-膦酸酯转化为未保护的核苷酸加合物,其各种盐未能形成适合X射线分析的晶体。尽管通过脱氧鸟苷酸与外消旋二醇环氧化物的直接反应已形成亚毫克量的这种化合物作为混合非对映异构体,但本研究代表了哺乳动物中由苯并[a]芘形成的主要DNA加合物作为其3'-磷酸酯的首次实际合成。